Sensex

Nifty

USDINR

GBPINR

EURINR

Tuesday, 24 February 2026 12:00 AM EOD	Asian-Paints2413.25	Hind-Unilever2359.30	ITC323.55	Trent3934.65	Larsen-and-Toubro4258.50	M-and-M3429.90	Reliance-Industries1430.15	Tata-Steel209.15	Titan-Company4294.20	SBI1223.85	Bharat-Electron435.00	Kotak-Mah-Bank427.60	Infosys1276.55	Bajaj-Finance1023.80	Sun-PharmaInds1730.55	HDFC-Bank910.70	TCS2574.50	ICICI-Bank1384.80	Power-Grid-Corpn304.85	Maruti-Suzuki14924.40	Axis-Bank1387.65	HCL-Technologies1339.40	NTPC382.75	Bharti-Airtel1940.70	Tech-Mahindra1346.55	Adani-Ports1555.25	UltraTech-Cem12951.50	Bajaj-Finserv2046.05	Interglobe-Aviat4850.20	Eternal253.95
15 mins delay SENSEX 82,225.92 [-1,068.74]	-15.50 -0.64%	14.45 0.62%	-1.80 -0.55%	-118.75 -2.93%	-158.65 -3.59%	-15.10 -0.44%	2.25 0.16%	1.10 0.53%	21.85 0.51%	-3.95 -0.32%	-4.70 -1.07%	-3.10 -0.72%	-51.90 -3.91%	-7.25 -0.70%	-1.65 -0.10%	-13.15 -1.42%	-101.35 -3.79%	-14.30 -1.02%	1.50 0.49%	-143.30 -0.95%	1.10 0.08%	-86.95 -6.10%	7.30 1.94%	-56.45 -2.83%	-95.20 -6.60%	-1.30 -0.08%	-23.00 -0.18%	-5.00 -0.24%	-11.05 -0.23%	-14.15 -5.28%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Alembic Pharma gets USFDA nod for antifungal ANDA

24-Feb-26 14:53Hrs IST

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). The said drug is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.

According to IQVIA, Efinaconazole Topical Solution, 10%, has an estimated market size of $500 million for twelve months ending December 2025.

The company has a cumulative total of 234 ANDA approvals (215 final approvals and 19 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development company, is engaged in the manufacture and marketing of generic pharmaceutical products across global markets. The company's consolidated net profit fell 3.9% to Rs 132.97 crore despite a 10.8% jump in net sales to Rs 1,876.31 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.31% to Rs 757 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise